June 21, 2011

General Nutrition Centers announced that its president and chief merchandising officer has resigned.

June 21, 2011

Elisa Technologies recently announced that its EZ Gluten test kit has earned Performance-Tested Methods certification from the AOAC Research Institute, a private, not-for-profit association that helps establish testing standards.

June 21, 2011

The Food and Drug Administration Tuesday approved the first generic versions of an antibiotic designed to treat certain infections in people ages 18 years and older.

June 21, 2011

The Department of Health and Human Services on Tuesday morning unveiled the nine graphic health warnings mandated by the Food and Drug Administration to appear on every pack of cigarettes sold in the United States and in every cigarette advertisement.

June 21, 2011

Walgreens on Tuesday announced the company no longer will participate in the Express Scripts network beginning Jan. 1, 2012, citing unsuccessful renewal negotiations.

June 21, 2011

Soon after reporting double-digit earnings per share growth Tuesday morning, Walgreens announced it would forego as much as $5.3 billion in annual sales, representing some 7% of the company’s business and 90 million prescriptions, as it walks away from its relationship with pharmacy benefit manager Express Scripts.

June 21, 2011

Watson subsidiary Watson Labs is seeking approval for a drug designed to treat symptomatic benign prostatic hyperplasia in men with an enlarged prostate.

June 20, 2011

The Food and Drug Administration has approved a new formulation of an injectable drug made by Abbott for prostate cancer.

June 20, 2011

CVS/pharmacy has introduced its latest initiative, designed to underscore the role pharmacists play in managing ongoing medications for chronic illnesses, particularly when a patient starts a new medication.

June 20, 2011

A panel of Food and Drug Administration experts has recommended approval of an investigational biotech drug made by Regeneron Pharmaceuticals for eye diseases.

June 20, 2011

Johnson & Johnson is recalling 40,000 bottles of a drug used to treat schizophrenia due to consumer reports of the drug having a strange odor, the company said Friday.

June 20, 2011

Just after the approval of their new treatment for Type 2 diabetes, Eli Lilly and Boehringer Ingelheim plan to present data in more than two dozen presentations at the American Diabetes Association Scientific Sessions starting this week.

June 20, 2011

MusclePharm has introduced a sports nutrition supplements line through a licensing deal with MMA Elite of Ultimate Brand Management.

June 20, 2011

Mylan has scored a victory in its efforts to make a generic version of a Teva drug for multiple sclerosis.

June 20, 2011

A new study recently estimated that 5.9 million children in the United States suffer from a food allergy.

June 17, 2011

Armada Health Care and Emdeon have entered an agreement to support prior authorization management through Armada's ReachRx suite of services, Armada said.

June 17, 2011

Little Busy Bodies has introduced its latest Boogie Wipes product line that caters to adults' dry, chapped noses.

June 17, 2011

Many adults across the United States opted to visit their local drug store or supermarket to receive their flu shot during the 2010-2011 influenza season, according to the Centers for Disease Control and Prevention's "Morbidity and Mortality Weekly Report."

June 17, 2011

The North Carolina legislature passed a real-time, stop-sale system, which allows law-abiding citizens to access medicines containing pseudoephedrine, while stopping sales that exceed the legal limit.

June 17, 2011

A federal court has rejected Teva Pharmaceutical Industries’ efforts to prevent Watson from launching a generic version of one of its drugs, Watson said Friday.

June 17, 2011

The Food and Drug Administration on Thursday informed the public that continued use of a Type 2 diabetes treatment made by Takeda Pharmaceuticals for more than one year may be associated with an increased risk of bladder cancer.

June 17, 2011

A popular Type 2 diabetes treatment may help Type 1 diabetics achieve control of their blood-glucose levels, according to a small, observational study conducted at the University of Buffalo.

June 17, 2011

Nipro Diagnostics and NeuroMetrix have teamed up to market a point-of-care test that is designed to evaluate such systemic neuropathies as diabetic peripheral neuropathy.

June 17, 2011

The Food and Drug Administration has approved a drug for arthritis made by Watson Pharmaceuticals, Watson said Friday.